1. Home
  2. MLTX vs VIRT Comparison

MLTX vs VIRT Comparison

Compare MLTX & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • VIRT
  • Stock Information
  • Founded
  • MLTX 2021
  • VIRT 2008
  • Country
  • MLTX Switzerland
  • VIRT United States
  • Employees
  • MLTX N/A
  • VIRT N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • VIRT Investment Bankers/Brokers/Service
  • Sector
  • MLTX Health Care
  • VIRT Finance
  • Exchange
  • MLTX Nasdaq
  • VIRT Nasdaq
  • Market Cap
  • MLTX 2.8B
  • VIRT 3.3B
  • IPO Year
  • MLTX N/A
  • VIRT 2015
  • Fundamental
  • Price
  • MLTX $49.67
  • VIRT $44.21
  • Analyst Decision
  • MLTX Strong Buy
  • VIRT Hold
  • Analyst Count
  • MLTX 7
  • VIRT 8
  • Target Price
  • MLTX $73.33
  • VIRT $39.13
  • AVG Volume (30 Days)
  • MLTX 426.9K
  • VIRT 777.7K
  • Earning Date
  • MLTX 08-06-2025
  • VIRT 07-30-2025
  • Dividend Yield
  • MLTX N/A
  • VIRT 2.16%
  • EPS Growth
  • MLTX N/A
  • VIRT 142.03
  • EPS
  • MLTX N/A
  • VIRT 3.46
  • Revenue
  • MLTX N/A
  • VIRT $2,401,575,000.00
  • Revenue This Year
  • MLTX $103.42
  • VIRT N/A
  • Revenue Next Year
  • MLTX N/A
  • VIRT N/A
  • P/E Ratio
  • MLTX N/A
  • VIRT $12.85
  • Revenue Growth
  • MLTX N/A
  • VIRT 43.16
  • 52 Week Low
  • MLTX $31.42
  • VIRT $22.66
  • 52 Week High
  • MLTX $58.26
  • VIRT $45.18
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 62.21
  • VIRT 56.95
  • Support Level
  • MLTX $46.37
  • VIRT $42.53
  • Resistance Level
  • MLTX $49.29
  • VIRT $45.18
  • Average True Range (ATR)
  • MLTX 1.91
  • VIRT 1.00
  • MACD
  • MLTX 0.13
  • VIRT -0.03
  • Stochastic Oscillator
  • MLTX 70.19
  • VIRT 63.40

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About VIRT Virtu Financial Inc.

Virtu Financial Inc is a financial firm that leverages cutting edge technology to deliver liquidity to the global markets and innovative, transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.

Share on Social Networks: